Suliman Alsagaby

31PUBLICATIONS
85CO-AUTHORS
Biologically active moleculesMedical biochemistry and metabolomics not elsewhere classifiedCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (31)

|Feb 06, 2026
Anticancer Molecular Mechanisms of Phytosterols: An Updated Review on Clinical Trials.

Muhammad Shahbaz, Ushna Momal, Asfa Perween

|Jan 27, 2026
Correction: Althenayyan et al. Alternatively Spliced Isoforms of MUC4 and ADAM12 as Biomarkers for Colorectal Cancer Metastasis. J. Pers. Med. 2023, 13, 135.

Saleh Althenayyan, Mohammed H AlMuhanna, Abdulkareem AlAbdulrahman

|Nov 03, 2025
Elucidating the Anticancer Mechanisms of Tetrahydroxycurcumin: A Comprehensive Review of Preclinical Studies.

Muhammad Shahbaz, Ushna Momal, Hagar M Mohamed

|Sep 30, 2024
Biological roles of THRAP3, STMN1 and GNA13 in human blood cancer cells.

Suliman A Alsagaby

|Apr 28, 2023
Inhibitory Potential of the Ocimum sanctum Phytochemicals on Bruton's Tyrosine Kinase, a Well-Known Drug Target for Treatment of Chronic Lymphocytic Leukemia: An In Silico Investigation.

Shabir Ahmad Mir, Yahya Madkhali, Ahmad Firoz

|Jan 21, 2023
Alternatively Spliced Isoforms of MUC4 and ADAM12 as Biomarkers for Colorectal Cancer Metastasis.

Saleh Althenayyan, Mohammed H AlMuhanna, Abdulkareem AlAbdulrahman

Pageof 6

Frequent Collaborators

8 joint publications

Fahad A Alhumaydhi

7 joint publications

Waleed Al Abdulmonem

6 joint publications

Saeed Banawas

6 joint publications

Danish Iqbal